{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:53Z","timestamp":1791461453867,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jneuroim.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T20:16:44Z","timestamp":1356207404000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis"],"prefix":"10.1016","volume":"256","author":[{"given":"Weifan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Windy","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.11.003_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cellimm.2011.07.007","article-title":"Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis","volume":"271","author":"Allman","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1196\/annals.1254.056","article-title":"Standards of measurement in myasthenia gravis","volume":"998","author":"Barohn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0015","first-page":"959","article-title":"Incidence of seropositive myasthenia gravis in Cape Town and South Africa","volume":"97","author":"Bateman","year":"2007","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/0-387-24180-9_17","article-title":"Role of complement receptor 2 in the pathogenesis of systemic lupus erythematosus","volume":"560","author":"Boackle","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08916930410001685063","article-title":"CR1\/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL\/lpr model of SLE","volume":"37","author":"Boackle","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1196\/annals.1405.009","article-title":"Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis","volume":"1132","author":"Christadoss","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0035","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.4049\/jimmunol.175.8.5379","article-title":"A critical role for complement C3d and the B cell coreceptor (CD19\/CD21) complex in the initiation of inflammatory arthritis","volume":"175","author":"Del Nagro","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell. Res."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0045","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.molimm.2009.05.181","article-title":"Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions","volume":"46","author":"Erdei","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","article-title":"Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes","volume":"146","author":"Fischer","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00296-004-0541-2","article-title":"Soluble CD21 in sera and synovial fluid of arthritic patients","volume":"26","author":"Grottenthaler","year":"2006","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0060","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.molimm.2009.04.036","article-title":"Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2\/CD21","volume":"46","author":"Hoefer","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0065","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.molimm.2007.12.015","article-title":"Modulation of murine complement receptor type 2(CR2\/CD21) ectodomain shedding by its cytoplasmic domain","volume":"45","author":"Hoefer","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00281-004-0186-y","article-title":"Complement receptors and the shaping of the natural antibody repertoire","volume":"26","author":"Holers","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molimm.2006.07.003","article-title":"Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation","volume":"44","author":"Holers","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/08916930600739001","article-title":"The role of CR2 in autoimmunity","volume":"39","author":"Isa\u00e1k","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/intimm\/dxm132","article-title":"Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients","volume":"20","author":"Isa\u00e1k","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/00207454.2011.596293","article-title":"Evaluation of serum IgG subclass concentrations in myasthenia gravis","volume":"121","author":"Liu","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0095","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/eji.200323843","article-title":"B cell activation leads to shedding of complement receptor type II (CR2\/CD21)","volume":"33","author":"Masilamani","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.0300-9475.2004.01494.x","article-title":"Reduction of soluble complement receptor 2\/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis","volume":"60","author":"Masilamani","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/keg449","article-title":"Decreased levels of serum soluble complement receptor-II (CR2\/CD21) in patients with rheumatoid arthritis","volume":"43","author":"Masilamani","year":"2004","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.imlet.2007.12.007","article-title":"Novel roles for murine complement receptors type1 and 2 I. Regulation of B cell survival and proliferation by CR1\/2","volume":"116","author":"Moln\u00e1r","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2006.04.014","article-title":"The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Ig\u03b1 cytoplasmic domain","volume":"25","author":"Patterson","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.2007.00556.x","article-title":"Complement receptors CD21 and CD35 in humoral immunity","volume":"219","author":"Roozendaal","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00296-007-0503-6","article-title":"Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies","volume":"28","author":"Singh","year":"2008","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00296-011-1830-1","article-title":"Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis","volume":"32","author":"Singh","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2011.11.002","article-title":"The role of the Epstein\u2013Barr virus receptor CD21 in multiple sclerosis","volume":"242","author":"Toepfner","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0150","first-page":"15","article-title":"A review of myasthenia gravis: pathogenesis, clinical features and treatment","volume":"18","author":"Turner","year":"2007","journal-title":"Curr. Anaesth. Crit. Care"},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0155","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.171.7.3847","article-title":"Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis","volume":"171","author":"T\u00fcz\u00fcn","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0160","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.172.9.5743","article-title":"Circulating immune complexes augment severity of antibody mediated myasthenia gravis in hypogammaglobulinemic RIIIS\/J mice","volume":"172","author":"T\u00fcz\u00fcn","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0165","first-page":"265","article-title":"Targeting classical complement pathway to treat complement mediated autoimmune diseases","volume":"632","author":"T\u00fcz\u00fcn","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"T\u00fcz\u00fcn","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0175","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.molimm.2009.03.007","article-title":"Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice","volume":"46","author":"Twohig","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrd3011","article-title":"Therapeutic potential of complement modulation","volume":"9","author":"Wagner","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","article-title":"A new CD21 low B cell population in the peripheral blood of patients with SLE","volume":"113","author":"Wehr","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0190","first-page":"8","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"15","author":"Wu","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jneuroim.2012.11.003_bb0195","first-page":"546","article-title":"Expression of CD21 in peripheral blood B lymphocytes of neonates","volume":"9","author":"Zhang","year":"2007","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812003323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812003323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:54Z","timestamp":1759047594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812003323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0165572812003323"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.11.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}